Biochemical Diagnostic Markers to Detect Early Alzheimer’s Disease
Author:
- 1 March 1998
- journal article
- review article
- Published by Elsevier in Neurobiology of Aging
- Vol. 19 (2) , 165-167
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Amyloid, the presenilins and Alzheimer's diseaseTrends in Neurosciences, 1997
- Cerebrospinal Fluid Levels of -Secretase--Cleaved Soluble Amyloid Precursor Protein Mirror Cognition in a Swedish Family With Alzheimer Disease and a Gene MutationArchives of Neurology, 1997
- Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele ϵ4 during 14 months follow-upNeuroscience Letters, 1996
- The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD familiesNature Genetics, 1995
- Increased cerebrospinal fluid tau in patients with Alzheimer's diseaseNeuroscience Letters, 1995
- Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation.Proceedings of the National Academy of Sciences, 1994
- A Large Swedish Family With Alzheimer's Disease With a Codon 670/671 Amyloid Precursor Protein MutationArchives of Neurology, 1994
- Increased β‐amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutationFEBS Letters, 1994
- Release of Excess Amyloid β Protein from a Mutant Amyloid β Protein PrecursorScience, 1993
- Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein productionNature, 1992